This is a Validated Antibody Database (VAD) review about human FasL, based on 15 published articles (read how Labome selects the articles), using FasL antibody in all methods. It is aimed to help Labome visitors find the most suited FasL antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FasL synonym: ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; FASL; TNFSF6; TNLG1A

Invitrogen
mouse monoclonal (NOK-1)
  • flow cytometry; human; loading ...; fig 4b
Invitrogen FasL antibody (eBioscience, NOK-1) was used in flow cytometry on human samples (fig 4b). BMC Immunol (2020) ncbi
mouse monoclonal (NOK-1)
  • flow cytometry; human; fig 2
In order to study chronic hepatitis C virus infections and the functional dichotomy of V-delta2 gamma-delta T cells and their role in cytotoxicity and not IFN-gamma production, Invitrogen FasL antibody (eBioscience, NOK-1) was used in flow cytometry on human samples (fig 2). Sci Rep (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (NOK-1)
  • western blot; rat; 1:200; loading ...; fig 5c
Santa Cruz Biotechnology FasL antibody (Santa Cruz Biotechnology, sc-19681) was used in western blot on rat samples at 1:200 (fig 5c). Int J Nanomedicine (2020) ncbi
BioLegend
mouse monoclonal (NOK-1)
  • flow cytometry; human; loading ...; fig 3d
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, BioLegend FasL antibody (BioLegend, NOK-1) was used in flow cytometry on human samples (fig 3d). Oncoimmunology (2017) ncbi
mouse monoclonal (NOK-1)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BioLegend FasL antibody (BioLegen d, 306407) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (NOK-1)
  • blocking or activating experiments; human; fig 4
BioLegend FasL antibody (biolegend, NOK-1) was used in blocking or activating experiments on human samples (fig 4). Leuk Res (2015) ncbi
R&D Systems
mouse monoclonal (100419)
  • blocking or activating experiments; human; loading ...; fig s2
R&D Systems FasL antibody (R&D Systems, MAB126) was used in blocking or activating experiments on human samples (fig s2). Cell Death Differ (2017) ncbi
mouse monoclonal (100419)
  • blocking or activating experiments; human; loading ...; fig s2a
R&D Systems FasL antibody (R&D Systems, MAB126) was used in blocking or activating experiments on human samples (fig s2a). Cell Death Dis (2017) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:500; fig 4
Abcam FasL antibody (Abcam, ab15285) was used in western blot on human samples at 1:500 (fig 4). Onco Targets Ther (2016) ncbi
Bio-Rad
mouse monoclonal (14C2)
  • flow cytometry; human; fig s3
Bio-Rad FasL antibody (AbD Serotec, 14C2) was used in flow cytometry on human samples (fig s3). PLoS Pathog (2016) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig s3j
In order to elucidate that mTORC1 presents tumor suppressor features in conditions of nutrient restrictions, Cell Signaling Technology FasL antibody (Cell Signaling, 4273) was used in western blot on human samples at 1:1000 (fig s3j). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 4
Cell Signaling Technology FasL antibody (Cell Signaling Tech, 4273S) was used in western blot on human samples at 1:1000 (fig 4). Mol Med Rep (2016) ncbi
BD Biosciences
mouse monoclonal (NOK-1)
  • flow cytometry; human; loading ...; fig 3a
In order to characterize CD8 positive alpha beta gamma delta T cells, BD Biosciences FasL antibody (BD Biosciences, Nok-1) was used in flow cytometry on human samples (fig 3a). J Immunol (2016) ncbi
mouse monoclonal (G247-4)
  • immunocytochemistry; human; fig 5
BD Biosciences FasL antibody (BD Pharmingen, G247-4) was used in immunocytochemistry on human samples (fig 5). Photochem Photobiol (2015) ncbi
mouse monoclonal (NOK-1)
  • western blot; rat
  • immunocytochemistry; human
BD Biosciences FasL antibody (BD Pharmingen, 556373) was used in western blot on rat samples and in immunocytochemistry on human samples . Toxicol Lett (2015) ncbi
Articles Reviewed
  1. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  2. Lin Y, Huang X, Chang K, Liao K, Tsai N. Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood-Brain Barrier and Suppresses Growth of Glioblastoma. Int J Nanomedicine. 2020;15:749-760 pubmed publisher
  3. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  4. Villar V, Nguyen T, Delcroix V, Terés S, Bouchecareilh M, Salin B, et al. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation. Nat Commun. 2017;8:14124 pubmed publisher
  5. Tanzer M, Khan N, Rickard J, Etemadi N, Lalaoui N, Spall S, et al. Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways. Cell Death Differ. 2017;24:481-491 pubmed publisher
  6. Guicciardi M, Krishnan A, Bronk S, Hirsova P, Griffith T, Gores G. Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice. Cell Death Dis. 2017;8:e2535 pubmed publisher
  7. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  8. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  9. Liu Y, Wang Y, Ding G, Yang T, Yao L, Hua J, et al. JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway. Onco Targets Ther. 2016;9:4425-33 pubmed publisher
  10. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed publisher
  11. Cheng C, Jiao J, Qian Y, Guo X, Huang J, Dai M, et al. Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells. Mol Med Rep. 2016;13:3763-70 pubmed publisher
  12. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  13. Salva K, Wood G. Epigenetically Enhanced Photodynamic Therapy (ePDT) is Superior to Conventional Photodynamic Therapy for Inducing Apoptosis in Cutaneous T-Cell Lymphoma. Photochem Photobiol. 2015;91:1444-51 pubmed publisher
  14. Zhang L, Wang H, Ding K, Xu J. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells. Toxicol Lett. 2015;236:43-59 pubmed publisher
  15. Difranco K, Johnson Farley N, Bertino J, Elson D, Vega B, Belinka B, et al. LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes. Leuk Res. 2015;39:649-56 pubmed publisher